does tirzepatide cause bone loss A study presented at the #AAOS2026 Annual Meeting revealed GLP-1 receptor agonist use was associated with a 29% higher risk of osteoporosis after five years. As these medications become more widely used Long-Term Tirzepatide Effects on Weight

And I really think that that was the big change in my perspective and the best evidence for this, and I cite two examples in the book, which I think are two of the largest examples, is when you contrast the effect of treating patients with metastatic cancer versus treating patients in the adjuvant setting for the same cancer with the same drug

Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure

If you are considering both GLP-1 therapy and plasma donation, sharing your genetic test results with your medical team can support a collaborative decision-making process

Retatrutides triple-receptor agonismmainly the inclusion of the glucagon receptorprovides a superior metabolic advantage in clearing liver fat and increasing thermogenesis compared to dual agonists